pexidartinib
Sign in to saveAlso known as PLX-3397, PLX3397
Pexidartinib, sold under the brand name Turalio, is a kinase inhibitor drug for the treatment of adults with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery. Pexidartinib blocks the activity of the colony-stimulating factor-1 receptor (CSF-1R).
~5 min read
Encyclopedic overview
4 sectionsContents
- History
- References
- Further reading
- External links
{{Infobox drug | drug_name = | INN = | type = | image = Pexidartinib.svg | image_class = skin-invert-image | width = | alt = | caption =
| pronounce = | tradename = Turalio | Drugs.com = | MedlinePlus = a619050 | licence_CA = | licence_EU = | DailyMedID = Pexidartinib | licence_US = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATCvet = | ATC_prefix = L01 | ATC_suffix = EX15
Excerpted from Wikipedia’s “pexidartinib” article, available under the CC BY-SA 4.0 licence.